康缘药业:获得泻白散颗粒药品注册证书

Core Viewpoint - Kangyuan Pharmaceutical has received a drug registration certificate for Xiebaisan Granules from the National Medical Products Administration, indicating a significant regulatory milestone for the company [1] Group 1: Product Details - The drug's generic name is Xiebaisan Granules, with main ingredients including fried mulberry bark, prepared lycium bark, fried licorice, and glutinous rice [1] - The dosage form is granules, with a specification equivalent to 8.20g of decoction pieces per bag [1] - The registration classification is Traditional Chinese Medicine Class 3.1, and the drug has a shelf life of 18 months, classified as a prescription drug [1]

Kanion Pharmaceutical-康缘药业:获得泻白散颗粒药品注册证书 - Reportify